Evaluation of the MISHA Knee System for treating knee osteoarthritis
Official title: Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis
Run by Moximed · NCT06118892 · Data updated 2026-11-12
This study is testing a new knee treatment called the MISHA Knee System to see if it helps people with knee osteoarthritis feel less pain and improve their function over five years.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 65 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Moximed Industry-sponsored |
| Locations | 4 sites (Sonoma, California and 3 other locations) |
| Status | Recruiting |
| Started | November 3, 2023 |
| Main results expected | June 30, 2030 |
| Study ends | July 30, 2030 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT06118892 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 25 to 65 with isolated medial compartment knee pain and a BMI under 35 who have not responded to non-operative treatments.
✕Probably not a fit
Patients with significant knee structural issues, such as large osteophytes or poor bone quality, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and effectiveness of the MISHA Knee System in patients with osteoarthritis of the knee. It involves a prospective collection of data on various outcomes, including pain and function scores, satisfaction levels, and adverse events over a five-year period following the procedure. Participants will be monitored for device performance, including the rate of surgical site infections and the need for further surgical interventions. The study aims to provide insights into the long-term benefits and risks associated with this knee treatment.
Why it matters
Potential benefit: If successful, this study could provide a new effective treatment option for patients suffering from knee osteoarthritis.
How similar studies have gone: Other studies have shown promising results with similar knee treatment approaches, indicating potential for success in this evaluation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Key Inclusion Criteria: 1. Subjects aged 25 to 65 years at time of index procedure 2. Body Mass Index (BMI) of \< 35 3. Activity exacerbated knee pain isolated to the medial compartment and not global in nature 4. WOMAC pain ≥ 40 5. Failed non-operative OA treatment Key Exclusion Criteria: 1. Large medial osteophyte(s) or considerable extruded meniscus that may interfere with the placement or function of the device 2. Poor bone quality (e.g., bony erosion, osteopenia, osteoporosis) 3. Ligamentous instability 4. Active or recent knee infection 5. Inflammatory joint disease, including sequalae of viral infections 6. Suspected or documented allergy or hypersensitivity to cobalt, chromium, nickel or other metals 7. History of keloid, hypertrophic or contracture scaring 8. Propensity for restrictive scar formation or adhesions with prior procedures
Where it's running
-
Weiss Orthopedics
Sonoma, California, United States Recruiting -
Orthopaedics Specialists of NC
Raleigh, North Carolina, United States Recruiting -
Oregon Health and Science University
Portland, Oregon, United States Recruiting -
University of Virginia
Charlottesville, Virginia, United States Recruiting
Study contacts
- Principal investigator: Dennis Crawford, MD — Oregon Health and Science University
- Study coordinator: Rose Weinstein
- Email: rsweinstein@moximed.com
- Phone: (510) 887 3375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Arthrosamid versus steroid injections for managing knee osteoarthritis.
This trial will test whether a single Arthrosamid hydrogel injection works better than a standard steroid plus local anesthetic injection for adults with symptomatic knee osteoarthritis.
-
Platelet-rich plasma plus hyaluronic acid injections for knee osteoarthritis
We will try a single injection of platelet-rich plasma plus hyaluronic acid, platelet-rich plasma alone, or hyaluronic acid alone to see which works best for adults (40–75) with unilateral knee osteoarthritis who still have pain after conservative treatment.
-
Evaluating OA-SYS for knee osteoarthritis treatment
This study is testing a new treatment called OA-SYS using adult stem cells to see if it can help people with moderate to severe knee osteoarthritis feel better and improve their knee function.
-
Using bioceramic materials to repair bone defects
This study is testing if a new type of bioceramic implant can help people heal better from bone defects compared to a standard bone implant.
-
Evaluating Metformin for Knee Osteoarthritis
This study is testing if Metformin can help people aged 30 to 60 with knee osteoarthritis feel better and improve their joint function compared to another medication.
-
Comparing the effects of a vegan diet to an omnivorous diet before knee surgery
This study is testing whether a vegan diet for two weeks before knee surgery can help older adults with knee osteoarthritis build protein in their muscles and tissues better than a regular diet with meat.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.